Similar articles

• Abbreviated hormone replacement therapy trial answers some questions, raises new ones. The Women's Health Initiative is no longer testing the most widely prescribed estrogen and progestin combination--but the study's job is far from over.

  [No authors listed] [No authors listed] Harv Womens Health Watch. 2002 Oct;10(2):2-4. Harv Womens Health Watch. 2002. PMID: 12393317 No abstract available.
• So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.

  Twombly R. Twombly R. J Natl Cancer Inst. 2007 Dec 19;99(24):1828-9, 1835. doi: 10.1093/jnci/djm285. Epub 2007 Dec 11. J Natl Cancer Inst. 2007. PMID: 18073368 No abstract available.
• Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.

  Langer RD. Langer RD. Am J Epidemiol. 2009 Mar 15;169(6):784-5; author reply 785-6. doi: 10.1093/aje/kwn420. Epub 2009 Feb 10. Am J Epidemiol. 2009. PMID: 19208722 No abstract available.
• A clinician's review of the WHI-related literature.

  Speroff L. Speroff L. Int J Fertil Womens Med. 2004 Nov-Dec;49(6):252-67. Int J Fertil Womens Med. 2004. PMID: 15751264 Review.
• New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.

  Modena MG, Sismondi P, Mueck AO, Kuttenn F, Lignières Bd, Verhaeghe J, Foidart JM, Caufriez A, Genazzani AR; TREAT. Modena MG, et al. Maturitas. 2005 Sep 16;52(1):1-10. doi: 10.1016/j.maturitas.2005.05.003. Maturitas. 2005. PMID: 15963666 Review.